Home > Expanded Access > Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Boehringer Ingelheim

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Official Title: 
An Open Label, Non-randomized Treatment Protocol of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Protease Inhibitor-experienced Patients With HIV-1 Infection (the Tipranavir Expanded Access Program)
Brief Summary: 
This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
Approved for marketing
HIV Infections

Drug: Tipranavir
500 mg twice daily

Drug: Ritonavir
200 mg twice daily

Countries: 
United States
Locations: 

1182.70.127 Health Services Center, Inc.
Anniston, Alabama,

1182.70.006 Spectrum Medical Group
Phoenix, Arizona,

1182.70.016 Health for Life Clinic
Little Rock, Arkansas,

1182.70.065
Anaheim, California,

1182.70.246
Baldwin Park, California,

1182.70.043
Fountain Valley, California,

1182.70.092
Fresno, California,

1182.70.057
Glendale, California,

1182.70.064
Harbor City, California,

1182.70.079
Long Beach, California,

1182.70.015
Los Angeles, California,

1182.70.053
Los Angeles, California,

1182.70.066
Los Angeles, California,

1182.70.071
Los Angeles, California,

1182.70.137
Los Angeles, California,

1182.70.198
Los Angeles, California,

1182.70.008
Newport Beach, California,

1182.70.081
Oakland, California,

1182.70.095
Oakland, California,

1182.70.067
Panorama City, California,

1182.70.033
San Diego, California,

1182.70.014
San Francisco, California,

1182.70.020
San Francisco, California,

1182.70.048
San Francisco, California,

1182.70.085
San Francisco, California,

1182.70.214
San Francisco, California,

1182.70.022
San Rafael, California,

1182.70.222
Stanford, California,

1182.70.005
Tarzana, California,

1182.70.030
Tarzana, California,

1182.70.068
Woodland Hills, California,

1182.70.218 Denver Infectious Disease Consultants
Denver, Colorado,

1182.70.281
Denver, Colorado,

1182.70.074
New Haven, Connecticut,

1182.70.073
Norwich, Connecticut,

1182.70.032
Washington, District of Columbia,

1182.70.042
Washington, District of Columbia,

1182.70.289 Dupont Circle Physicians Group
Washington, District of Columbia,

1182.70.003
Fort Lauderdale, Florida,

1182.70.013
Fort Lauderdale, Florida,

1182.70.049
Fort Lauderdale, Florida,

1182.70.096
Fort Lauderdale, Florida,

1182.70.045
Fort Myers, Florida,

1182.70.026
Hollywood, Florida,

1182.70.023
Miami, Florida,

1182.70.040
North Palm Beach, Florida,

1182.70.007
Orlando, Florida,

1182.70.117
Plantation, Florida,

1182.70.017
Pompano Beach, Florida,

1182.70.047
West Palm Beach, Florida,

1182.70.002
Atlanta, Georgia,

1182.70.046
Atlanta, Georgia,

1182.70.069
Atlanta, Georgia,

1182.70.037
Dactur, Georgia,

1182.70.058
Jesup, Georgia,

1182.70.174
Macon, Georgia,

1182.70.019
Chicago, Illinois,

1182.70.029 Dr. David Moore
Chicago, Illinois,

1182.70.194
Chicago, Illinois,

1182.70.010
Joliet, Illinois,

1182.70.167
Indianapolis, Indiana,

1182.70.192
Iowa City, Iowa,

1182.70.099
New Orleans, Louisiana,

1182.70.025 Chase Brexton Health Services, Inc
Baltimore, Maryland,

1182.70.082
Boston, Massachusetts,

1182.70.090
Boston, Massachusetts,

1182.70.004
Berkley, Michigan,

1182.70.084
Detroit, Michigan,

1182.70.035
St. Louis, Missouri,

1182.70.242
St. Louis, Missouri,

1182.70.093
Lincoln, Nebraska,

1182.70.021
Las Vegas, Nevada,

1182.70.288 Hackensack University Medical Center
Hackensack, New Jersey,

1182.70.075
Sommers Point, New Jersey,

1182.70.024
Briarcliff Manor, New York,

1182.70.105
Bronk, New York,

1182.70.250 Montefiore Medical Center
Bronx, New York,

1182.70.039
Kingston, New York,

1182.70.028
New York, New York,

1182.70.031
New York, New York,

1182.70.036
New York, New York,

1182.70.050
New York, New York,

1182.70.062
New York, New York,

1182.70.104
New York, New York,

1182.70.086 Boehringer Ingelheim Investigational Site
Rochester, New York,

1182.70.061
Asheville, North Carolina,

1182.70.100
Chapel Hill, North Carolina,

1182.70.136 Mecklenburg Medical Group, P.A.
Charlotte, North Carolina,

1182.70.103
Durham, North Carolina,

1182.70.241 University of CIncinnati Medical Center
Cincinnati, Ohio,

1182.70.044
Portland, Oregon,

1182.70.059 Fanno Creek Clinic
Portland, Oregon,

1182.70.077 Kaiser Permanente-IDC
Portland, Oregon,

1182.70.051
Philadelphia, Pennsylvania,

1182.70.080
Philadelphia, Pennsylvania,

1182.70.072
Providence, Rhode Island,

1182.70.126
Charleston, South Carolina,

1182.70.271
Charleston, South Carolina,

1182.70.088
Columbia, South Carolina,

1182.70.165 Comprehensive Care Center
Nashville, Tennessee,

1182.70.018
Austin, Texas,

1182.70.038
Dallas, Texas,

1182.70.041
Dallas, Texas,

1182.70.055
Dallas, Texas,

1182.70.070
Dallas, Texas,

1182.70.060
El Paso, Texas,

1182.70.052
Houston, Texas,

1182.70.054
Houston, Texas,

1182.70.285
Houston, Texas,

1182.70.128 Olmos Park Medical Associates
San Antonio, Texas,

1182.70.011
Annadale, Virginia,

1182.70.217
Richmond, Virginia,

1182.70.097
Seattle, Washington,

1182.70.76
Seattle, Washington,

1182.70.083
Spokane, Washington,

Boehringer Ingelheim
Study Chair
Boehringer Ingelheim

Boehringer Ingelheim
EA Number: 
MeSH Terms: 
Infection, Communicable Diseases, HIV Infections, Ritonavir, Tipranavir
Disclaimer:
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.